List of Tables
Table 1. Influenza Virus Vector Vaccine Market Trends
Table 2. Influenza Virus Vector Vaccine Market Drivers & Opportunity
Table 3. Influenza Virus Vector Vaccine Market Challenges
Table 4. Influenza Virus Vector Vaccine Market Restraints
Table 5. Global Influenza Virus Vector Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Influenza Virus Vector Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Influenza Virus Vector Vaccine Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Influenza Virus Vector Vaccine Product Type
Table 9. Key Companies Time to Begin Mass Production of Influenza Virus Vector Vaccine
Table 10. Global Influenza Virus Vector Vaccine Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Virus Vector Vaccine as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Influenza Virus Vector Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Influenza Virus Vector Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Influenza Virus Vector Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Influenza Virus Vector Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Influenza Virus Vector Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Influenza Virus Vector Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Influenza Virus Vector Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Influenza Virus Vector Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Influenza Virus Vector Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Influenza Virus Vector Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Influenza Virus Vector Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Influenza Virus Vector Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Influenza Virus Vector Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Influenza Virus Vector Vaccine Sales Value by Region (2019-2024) & (%)
Table 27. Global Influenza Virus Vector Vaccine Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Influenza Virus Vector Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Influenza Virus Vector Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Influenza Virus Vector Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 31. GREFFEX Basic Information List
Table 32. GREFFEX Description and Business Overview
Table 33. GREFFEX Influenza Virus Vector Vaccine Products, Services and Solutions
Table 34. Revenue (US$ Million) in Influenza Virus Vector Vaccine Business of GREFFEX (2019-2024)
Table 35. GREFFEX Recent Developments
Table 36. CanSino Biologics Basic Information List
Table 37. CanSino Biologics Description and Business Overview
Table 38. CanSino Biologics Influenza Virus Vector Vaccine Products, Services and Solutions
Table 39. Revenue (US$ Million) in Influenza Virus Vector Vaccine Business of CanSino Biologics (2019-2024)
Table 40. CanSino Biologics Recent Developments
Table 41. Academy of Military Medical Sciences Basic Information List
Table 42. Academy of Military Medical Sciences Description and Business Overview
Table 43. Academy of Military Medical Sciences Influenza Virus Vector Vaccine Products, Services and Solutions
Table 44. Revenue (US$ Million) in Influenza Virus Vector Vaccine Business of Academy of Military Medical Sciences (2019-2024)
Table 45. Academy of Military Medical Sciences Recent Developments
Table 46. XMU Basic Information List
Table 47. XMU Description and Business Overview
Table 48. XMU Influenza Virus Vector Vaccine Products, Services and Solutions
Table 49. Revenue (US$ Million) in Influenza Virus Vector Vaccine Business of XMU (2019-2024)
Table 50. XMU Recent Developments
Table 51. HKU Basic Information List
Table 52. HKU Description and Business Overview
Table 53. HKU Influenza Virus Vector Vaccine Products, Services and Solutions
Table 54. Revenue (US$ Million) in Influenza Virus Vector Vaccine Business of HKU (2019-2024)
Table 55. HKU Recent Developments
Table 56. Hualan Biological Engineering Basic Information List
Table 57. Hualan Biological Engineering Description and Business Overview
Table 58. Hualan Biological Engineering Influenza Virus Vector Vaccine Products, Services and Solutions
Table 59. Revenue (US$ Million) in Influenza Virus Vector Vaccine Business of Hualan Biological Engineering (2019-2024)
Table 60. Hualan Biological Engineering Recent Developments
Table 61. BravoBio Basic Information List
Table 62. BravoBio Description and Business Overview
Table 63. BravoBio Influenza Virus Vector Vaccine Products, Services and Solutions
Table 64. Revenue (US$ Million) in Influenza Virus Vector Vaccine Business of BravoBio (2019-2024)
Table 65. BravoBio Recent Developments
Table 66. Key Raw Materials Lists
Table 67. Raw Materials Key Suppliers Lists
Table 68. Influenza Virus Vector Vaccine Downstream Customers
Table 69. Influenza Virus Vector Vaccine Distributors List
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Influenza Virus Vector Vaccine Product Picture
Figure 2. Global Influenza Virus Vector Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Influenza Virus Vector Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Influenza Virus Vector Vaccine Report Years Considered
Figure 5. Global Influenza Virus Vector Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Virus Vector Vaccine Revenue in 2023
Figure 7. Influenza Virus Vector Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Being Developed Picture
Figure 9. Preclinical Picture
Figure 10. Clinical I Picture
Figure 11. Clinical II Picture
Figure 12. Global Influenza Virus Vector Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Influenza Virus Vector Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Pharmaceutical And Biotechnology Companies
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Academic And Research Organizations
Figure 17. Product Picture of Other
Figure 18. Global Influenza Virus Vector Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Influenza Virus Vector Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Influenza Virus Vector Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Influenza Virus Vector Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Influenza Virus Vector Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Influenza Virus Vector Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Influenza Virus Vector Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Influenza Virus Vector Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Influenza Virus Vector Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Influenza Virus Vector Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Influenza Virus Vector Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Influenza Virus Vector Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Influenza Virus Vector Vaccine Sales Value (%), (2019-2030)
Figure 31. United States Influenza Virus Vector Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Influenza Virus Vector Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Influenza Virus Vector Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Influenza Virus Vector Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Influenza Virus Vector Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Influenza Virus Vector Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 37. China Influenza Virus Vector Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Influenza Virus Vector Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 39. China Influenza Virus Vector Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Influenza Virus Vector Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Influenza Virus Vector Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Influenza Virus Vector Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Influenza Virus Vector Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Influenza Virus Vector Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Influenza Virus Vector Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Influenza Virus Vector Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Influenza Virus Vector Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Influenza Virus Vector Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 49. India Influenza Virus Vector Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Influenza Virus Vector Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 51. India Influenza Virus Vector Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 52. Influenza Virus Vector Vaccine Industrial Chain
Figure 53. Influenza Virus Vector Vaccine Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
